药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
3-Methylfentanyl
Rozanolixizumab
The risk or severity of adverse effects can be increased when Tetrandrine is combined with Rozanolixizumab.
3-Methylfentanyl
Risankizumab
The risk or severity of adverse effects can be increased when Tetrandrine is combined with Risankizumab.
3-Methylfentanyl
Hydrocortisone succinate
The risk or severity of adverse effects can be increased when Tetrandrine is combined with Hydrocortisone succinate.
3-Methylfentanyl
Hydrocortisone acetate
The risk or severity of adverse effects can be increased when Tetrandrine is combined with Hydrocortisone acetate.
3-Methylfentanyl
Mometasone furoate
The risk or severity of adverse effects can be increased when Tetrandrine is combined with Mometasone furoate.
3-Methylfentanyl
Monomethyl fumarate
The risk or severity of adverse effects can be increased when Tetrandrine is combined with Monomethyl fumarate.
3-Methylfentanyl
Fluclorolone
The risk or severity of adverse effects can be increased when Fluclorolone is combined with Tetrandrine.
3-Methylfentanyl
Cloprednol
The risk or severity of adverse effects can be increased when Cloprednol is combined with Tetrandrine.
3-Methylfentanyl
Fluperolone
The risk or severity of adverse effects can be increased when Fluperolone is combined with Tetrandrine.
3-Methylfentanyl
Begelomab
The risk or severity of adverse effects can be increased when Begelomab is combined with Tetrandrine.
3-Methylfentanyl
Fluocortin
The risk or severity of adverse effects can be increased when Fluocortin is combined with Tetrandrine.
3-Methylfentanyl
Prednylidene
The risk or severity of adverse effects can be increased when Prednylidene is combined with Tetrandrine.
3-Methylfentanyl
9-(N-methyl-L-isoleucine)-cyclosporin A
The risk or severity of adverse effects can be increased when 9-(N-methyl-L-isoleucine)-cyclosporin A is combined with Tetrandrine.
3-Methylfentanyl
Hypericin
The risk or severity of adverse effects can be increased when Hypericin is combined with Tetrandrine.
3-Methylfentanyl
Cortivazol
The risk or severity of adverse effects can be increased when Cortivazol is combined with Tetrandrine.
3-Methylfentanyl
Acteoside
The risk or severity of adverse effects can be increased when Acteoside is combined with Tetrandrine.
3-Methylfentanyl
Deoxyspergualin
The risk or severity of adverse effects can be increased when Deoxyspergualin is combined with Tetrandrine.
3-Methylfentanyl
Doxifluridine
The risk or severity of adverse effects can be increased when Doxifluridine is combined with Tetrandrine.
3-Methylfentanyl
Trofosfamide
The risk or severity of adverse effects can be increased when Trofosfamide is combined with Tetrandrine.
3-Methylfentanyl
Cepeginterferon alfa-2B
The risk or severity of adverse effects can be increased when Cepeginterferon alfa-2B is combined with Tetrandrine.